Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Wayland Group Corp    WAYL   CA9442041062

WAYLAND GROUP CORP

(WAYL)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
1.11(c) 1.18(c) 1.15(c) 1.13(c) 1.16(c) Last
837 126 632 880 375 953 391 582 637 551 Volume
-9.76% +6.31% -2.54% -1.74% +2.65% Change
More quotes
Financials (CAD)
Sales 2018 10,3 M
EBIT 2018 -35,7 M
Net income 2018 -35,7 M
Debt 2018 -
Yield 2018 -
Sales 2019 124 M
EBIT 2019 -0,92 M
Net income 2019 -1,09 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 24,0x
Capi. / Sales2019 1,98x
Capitalization 246 M
More Financials
Company
Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on WAYLAND GROUP CORP
02/08WAYLAND : International Cannabis Applauds Receipt of EU-GMP Certification for Ge..
AQ
02/07WAYLAND : Receives EU-GMP Certification for German Facility
AQ
01/31WAYLAND : Comments on Recent Promotional Market Activity
AQ
01/30WAYLAND GROUP CORPORATION : European Cannabis Giant Wayland is said to be in adv..
EQ
01/22ICC INTERNATIONAL CANNABIS : International Cannabis and Wayland to Begin Integra..
AQ
01/21WAYLAND : International Cannabis and Wayland to Begin Integration of European Ex..
AQ
More news
Sector news : Alternative Medicine
02/15BRISTOL MYERS SQUIBB : Starboard gauges Bristol-Myers shareholder support for Ce..
RE
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -2-
DJ
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -- Journal Report
DJ
02/15WSJ TAX GUIDE 2019 : The Drug Industry -- Journal Report
DJ
More sector news : Alternative Medicine
Chart WAYLAND GROUP CORP
Duration : Period :
Wayland Group Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 2,50  CAD
Spread / Average Target 116%
EPS Revisions
Managers
NameTitle
Benjamin A. Ward Chief Executive Officer
Terry Fretz President
Sumesh Paul Pathak Chairman
Dan Healey Vice President-Operations
Scott M. Langille Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
WAYLAND GROUP CORP22.83%186
CANOPY GROWTH CORP71.57%16 260
AURORA CANNABIS INC39.09%7 009
BEIJING TONGRENTANG CO., LTD.4.58%5 828
DONG-E-E-JIAO CO LTD--.--%4 179
CRONOS GROUP INC95.48%3 791